Safety Study of XP12B in Women With Menorrhagia
Public ClinicalTrials.gov record NCT00113568. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multicenter Study to Evaluate the Safety of XP12B in Women With Heavy Menstrual Bleeding Associated With Menorrhagia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety of XP12B in women with heavy menstrual bleeding associated with menorrhagia.
Study identification
- NCT ID
- NCT00113568
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 784 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 49 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2005 (Type not available)
- Primary completion
- May 2009 (Actual)
- Completion
- May 2009 (Actual)
- Last update posted
- Jun 15, 2010
2005 – 2009
United States locations
- U.S. sites
- 59
- U.S. states
- 30
- U.S. cities
- 50
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigative Site | Birmingham | Alabama | 35235 | — |
| Investigative Site | Mobile | Alabama | 36608 | — |
| Investigative Site | Montgomery | Alabama | 36106 | — |
| Investigative Site | Phoenix | Arizona | 85032 | — |
| Investigative Site | Phoenix | Arizona | 85035 | — |
| Investigative Site | Jonesboro | Arkansas | 72401 | — |
| Investigative Site | Little Rock | Arkansas | 72205 | — |
| Investigative Site | San Diego | California | 92103 | — |
| Investigative Site | San Diego | California | 92108 | — |
| Investigative Site | Colorado Springs | Colorado | 80909 | — |
| Investigative Site | Denver | Colorado | 80202 | — |
| Investigative Site | Fort Myers | Florida | 33916 | — |
| Investigative Site | Miami | Florida | 33186 | — |
| Investigative Site | New Port Richey | Florida | 34652 | — |
| Investigative Site | Ocala | Florida | 34471 | — |
| Investigative Site | Pinellas Park | Florida | 33781 | — |
| Investigative Site | Venice | Florida | 34292 | — |
| Investigative Site | West Palm Beach | Florida | 33407 | — |
| Investigative Site | West Palm Beach | Florida | 33409 | — |
| Investigative Site | Alpharetta | Georgia | 30005 | — |
| Investigative Site | Roswell | Georgia | 30075 | — |
| Investigative Site | Savannah | Georgia | 31405 | — |
| Investigative Site | Savannah | Georgia | 31406 | — |
| Investigative Site | Boise | Idaho | 83702 | — |
| Investigative Site | Champaign | Illinois | 61820 | — |
| Investigative Site | Evansville | Indiana | 47713 | — |
| Investigative Site | Indianapolis | Indiana | 46250 | — |
| Investigative Site | South Bend | Indiana | 46601 | — |
| Investigative Site | Overland Park | Kansas | 66210 | — |
| Investigative Site | Lexington | Kentucky | 40536 | — |
| Investigative Site | Louisville | Kentucky | 40291 | — |
| Investigative Site | Shreveport | Louisiana | 71103 | — |
| Investigative Site | Portage | Michigan | 49024 | — |
| Investigative Site | Chaska | Minnesota | 55318 | — |
| Investigative Site | St Louis | Missouri | 63110 | — |
| Investigative Site | St Louis | Missouri | 63117 | — |
| Investigative Site | St Louis | Missouri | 63141 | — |
| Investigative Site | Billings | Montana | 59102 | — |
| Investigative Site | Omaha | Nebraska | 68131 | — |
| Investigative Site | Las Vegas | Nevada | 89030 | — |
| Investigative Site | Las Vegas | Nevada | 89128 | — |
| Investigative Site | Moorestown | New Jersey | 08057 | — |
| Investigative Site | Albuquerque | New Mexico | 87102 | — |
| Investigative Site | Johnson City | New York | 13790 | — |
| Investigative Site | Charlotte | North Carolina | 28209 | — |
| Investigative Site | Durham | North Carolina | 27710 | — |
| Investigative Site | Winston-Salem | North Carolina | 27103 | — |
| Investigative Site | Cincinnati | Ohio | 45249 | — |
| Investigative Site | Cincinnati | Ohio | 45267 | — |
| Investigative Site | Toledo | Ohio | 43614 | — |
| Investigative Site | Philadelphia | Pennsylvania | 19104 | — |
| Investigative Site | Wexford | Pennsylvania | 15090 | — |
| Investigative Site | Columbia | South Carolina | 29201 | — |
| Investigative Site | Nashville | Tennessee | 37203 | — |
| Investigative Site | Nashville | Tennessee | 37208 | — |
| Investigative Site | Houston | Texas | 77030 | — |
| Investigative Site | Norfolk | Virginia | 23507 | — |
| Investigative Site | Seattle | Washington | 98105 | — |
| Investigative Site | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00113568, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 15, 2010 · Synced Nov 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00113568 live on ClinicalTrials.gov.